BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23891320)

  • 1. [Corneal neovascularization: epidemiological, physiopathological, and clinical features].
    Benayoun Y; Casse G; Forte R; Dallaudière B; Adenis JP; Robert PY
    J Fr Ophtalmol; 2013 Sep; 36(7):627-39. PubMed ID: 23891320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imaging and quantification of corneal neovascularization].
    Benayoun Y; Rosenberg R; Casse G; Dallaudière B; Robert PY
    J Fr Ophtalmol; 2013 Oct; 36(8):693-703. PubMed ID: 23969009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory corneal neovascularization: etiopathogenesis.
    Clements JL; Dana R
    Semin Ophthalmol; 2011; 26(4-5):235-45. PubMed ID: 21958169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current treatments for corneal neovascularization].
    Benayoun Y; Petellat F; Leclerc O; Dost L; Dallaudière B; Reddy C; Robert PY; Salomon JL
    J Fr Ophtalmol; 2015 Dec; 38(10):996-1008. PubMed ID: 26522890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanisms of corneal neovascularization and modern options for its suppression].
    Mamikonyan VR; Pivin EA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(4):81-87. PubMed ID: 28635927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis).
    Azar DT
    Trans Am Ophthalmol Soc; 2006; 104():264-302. PubMed ID: 17471348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiogenesis and lymphangiogenesis in the cornea. Pathogenesis, clinical implications and treatment options].
    Cursiefen C; Seitz B; Dana MR; Streilein JW
    Ophthalmologe; 2003 Apr; 100(4):292-9. PubMed ID: 12682761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
    Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
    Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standardized semiquantitative analysis of corneal neovascularization using projected corneal photographs--pilot study after perforating corneal keratoplasty before immune reaction].
    Cursiefen C; Wenkel H; Martus P; Langenbucher A; Seitz B; Küchle M
    Klin Monbl Augenheilkd; 2001 Jul; 218(7):484-91. PubMed ID: 11512248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous corneal neovascularization in nude mice. Local imbalance between angiogenic and anti-angiogenic factors.
    Kaminska GM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):222-30. PubMed ID: 8425828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current methods of anti-angiogenic influence on newly formed corneal vessels].
    Vestn Oftalmol; 2013; 129(3):98-101. PubMed ID: 23879033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatments for corneal neovascularization: a review.
    Gupta D; Illingworth C
    Cornea; 2011 Aug; 30(8):927-38. PubMed ID: 21389854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel aspects of corneal angiogenic and lymphangiogenic privilege.
    Ellenberg D; Azar DT; Hallak JA; Tobaigy F; Han KY; Jain S; Zhou Z; Chang JH
    Prog Retin Eye Res; 2010 May; 29(3):208-48. PubMed ID: 20100589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune privilege and angiogenic privilege of the cornea.
    Cursiefen C
    Chem Immunol Allergy; 2007; 92():50-57. PubMed ID: 17264482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter mice.
    Heidenreich R; Murayama T; Silver M; Essl C; Asahara T; Rocken M; Breier G
    J Vasc Res; 2008; 45(5):437-44. PubMed ID: 18418002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal neovascularization: updates on pathophysiology, investigations & management.
    Sharif Z; Sharif W
    Rom J Ophthalmol; 2019; 63(1):15-22. PubMed ID: 31198893
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis.
    Quiroz-Mercado J; Ramírez-Velázquez N; Partido G; Zenteno E; Chávez R; Agundis-Mata C; Jiménez-Martínez MC; Garfias Y
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1753-63. PubMed ID: 27313162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal vascularization.
    Caffery BE; Josephson JE
    Optom Clin; 1995; 4(3):19-29. PubMed ID: 7767016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neovascularisation of the cornea].
    Mazhdrakova I; Demerdjieva Z
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):623-9. PubMed ID: 16118742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.